| For: | Hernández-Conde M, Llop E, Fernández Carrillo C, Tormo B, Abad J, Rodriguez L, Perelló C, López Gomez M, Martínez-Porras JL, Fernández Puga N, Trapero-Marugan M, Fraga E, Ferre Aracil C, Calleja Panero JL. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(42): 6658-6668 [PMID: 33268953 DOI: 10.3748/wjg.v26.i42.6658] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i42/6658.htm |
| Number | Citing Articles |
| 1 |
Vasilios Kotsis, Fernando Martinez, Christina Trakatelli, Josep Redon. Impact of Obesity in Kidney Diseases. Nutrients 2021; 13(12) doi: 10.3390/nu13124482
|
| 2 |
Deng-Hua He, Yong-Zhan Zhang, Liang Xu, Jia-Jia Pei, Ying Zhang, Zhong-Fang Yan. Relationship between metabolic associated fatty liver disease and body fat ratio, visceral fat area, and resting metabolic rate estimated by bioelectrical impedance analysis. World Chinese Journal of Digestology 2023; 31(2) doi: 10.11569/wcjd.v31.i2.56
Abstract(1215) |
Core Tip(893) |
Full Article(HTML)(5037)
|
Times Cited (0)
|
Total Visits (6276)
|
Open
|
| 3 |
Jian Yang, Chuan Wang Li, Jing Ru Zhang, Honglin Qiu, Xiu Li Guo, Wei Wang. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity 2023; doi: 10.2147/DMSO.S415477
|
| 4 |
M. Hernández-Conde, J.L. Calleja. La enfermedad hepática metabólica: una nueva pandemia prevenible. Revista de Gastroenterología de México 2023; 88(3) doi: 10.1016/j.rgmx.2022.04.002
|
| 5 |
Tatsuki Ichikawa, Mio Yamashima, Shinobu Yamamichi, Makiko Koike, Yusuke Nakano, Hiroyuki Yajima, Osamu Miyazaki, Tomonari Ikeda, Takuma Okamura, Kazuyoshi Nagata, Kenichi Sawa, Kazutaka Niiya, Kazuhiko Nakao. Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease. Biomedical Reports 2024; 21(4) doi: 10.3892/br.2024.1830
|
| 6 |
Semih Sezer, Selim Demirci. Preperitoneal fat thickness as a potential noninvasive marker for metabolic-associated liver disease: A retrospective study. Medicine 2025; 104(30) doi: 10.1097/MD.0000000000043584
|
| 7 |
M. Hernández-Conde, J.L. Calleja. Metabolic liver disease: A new preventable pandemic. Revista de Gastroenterología de México (English Edition) 2023; 88(3) doi: 10.1016/j.rgmxen.2022.04.003
|
| 8 |
Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Ou-Yang Huang, Rafael S. Rios, Kenneth I. Zheng, Sui-Dan Chen, Hong-Lei Ma, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2022; 10(3) doi: 10.14218/JCTH.2021.00286
|
| 9 |
Yasir Mohammed Khayyat. Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. World Journal of Hepatology 2021; 13(12): 2150-2160 doi: 10.4254/wjh.v13.i12.2150
|
| 10 |
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. Diabetes, Metabolic Syndrome and Obesity 2023; doi: 10.2147/DMSO.S431251
|
| 11 |
Giada Sebastiani, Nathalie Paisible, Cecilia Costiniuk, Joseph Cox, Dana Kablawi, Marina B. Klein, Nadine Kronfli, Jean-Pierre Routy, Julian Falutz, Bertrand Lebouché, Giovanni Guaraldi. The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics 2022; 12(11) doi: 10.3390/diagnostics12112590
|
| 12 |
Yongshuai Liu, Huijun Chang, Yunqing Zeng, Jinhou Li, Yueyue Li, Yong Chen, Tao Zhou, Yanjing Gao. Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-023-01996-9
|
| 13 |
Abhishek Yadav, Sunil Dadhich, Vivek Saini, Rajendra Bhati, Bobby Mitrolia. Body composition and changes with significant fibrosis in NAFLD: a cross-sectional analysis from a tertiary care center in Western India. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00441-z
|
| 14 |
Ashish Kumar, Anil Arora, Praveen Sharma, Shayesta Jan, Monika Taneja, Tarun Rajput. Assessing Body Fat in Obesity: Clinic and Home Monitoring Using a Portable Bioelectrical Impedance Analysis Device. Journal of The Association of Physicians of India 2026; 74(6) doi: 10.59556/japi.74.1545
|
| 15 |
Ashish Kumar, Anil Arora, Praveen Sharma, Shayesta Jan, Ishrat Ara. Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Clinical and Experimental Hepatology 2025; 15(1) doi: 10.1016/j.jceh.2024.102378
|
| 16 |
Ozge Kama Basci, Alihan Oral, Ali Kirik, Hacer Sen, Ihsan Solmaz, Ulas Serkan Topaloglu, Ismail Demir, Ahmet Dundar, Emine Binnetoglu, Nalan Okuroglu, Ahmet Aydin, Zeynep Irmak Kaya, Hamit Yildiz, Aycan Acet, Gokhan Tazegul, Osman Ozudogru, Kubilay Issever, Selcuk Yaylacı, Ugur Bayram Korkmaz, Nur Duzen Oflas, Celalettin Küçük, Kamil Konur, Teslime Ayaz, Aysun Isiklar, Esref Arac, Hilmi Erdem Sumbul, Hüseyin Ali Öztürk, Ali Burak Govez, Yusuf Usame Durmus, Atilla Onmez, Sibel Ocak Serin, Nizameddin Koca, Nazif Yalcin, Aysegul Ertinmaz, Alper Tuna Guven, Mehmet Kok, Yasin Sahinturk, Seyit Uyar, Hasan Sözel. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study. Diagnostics 2026; 16(4) doi: 10.3390/diagnostics16040547
|
| 17 |
Ker Ming Seaw, Christiani Jeyakumar Henry, Xinyan Bi. Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic Review. Livers 2023; 3(3) doi: 10.3390/livers3030033
|
| 18 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2) doi: 10.3390/life14020272
|